Increasing diversity in clinical trials
Update: 2024-06-27
Description
Drugmakers are taking steps to make sure clinical trials include participants from a variety of backgrounds—and they are steadily making progress, as evidenced by new studies of multiple sclerosis and sickle cell disease. Milliman health researchers Ellyn Russo and Chris Page unpack a history of distrust in medical research, the implications of failing to attract diverse study participants, and how simple strategies like rideshare vouchers, childcare, and check-in apps can help expand a study’s reach, so more patients have access to the latest treatments and medical research moves forward.
You can read the episode transcript on our website.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
